Safety and Efficacy of the Metabolic Profiling of the BIMRT Utilizing 18F FDG PET-CT

Aim: This study aims to evaluate the safety and efficacy of fluorodeoxyglucose positron emission tomography/computed tomography ( 18 F-FDG-PET/CT) guided intensity-modulated radiation therapy (IMRT) for patients with peritoneal metastases. Patients and Methods: A total of 55 patients with peritoneal...

Full description

Bibliographic Details
Main Authors: Ya-Zheng Dang MD, Dong-Xian Zhang MS, Guo-Dong Wang MS, Hong-Liang Zhao MS, Shi-Gao Huang PhD, Jie Li BS
Format: Article
Language:English
Published: SAGE Publishing 2020-09-01
Series:Technology in Cancer Research & Treatment
Online Access:https://doi.org/10.1177/1533033820960723
_version_ 1818508681320333312
author Ya-Zheng Dang MD
Dong-Xian Zhang MS
Guo-Dong Wang MS
Hong-Liang Zhao MS
Shi-Gao Huang PhD
Jie Li BS
author_facet Ya-Zheng Dang MD
Dong-Xian Zhang MS
Guo-Dong Wang MS
Hong-Liang Zhao MS
Shi-Gao Huang PhD
Jie Li BS
author_sort Ya-Zheng Dang MD
collection DOAJ
description Aim: This study aims to evaluate the safety and efficacy of fluorodeoxyglucose positron emission tomography/computed tomography ( 18 F-FDG-PET/CT) guided intensity-modulated radiation therapy (IMRT) for patients with peritoneal metastases. Patients and Methods: A total of 55 patients with peritoneal metastases were treated with 18F-FDG-PET/CT-guided IMRT (BIMRT) from January 2012 to January 2019. They were prescribed with a fraction of the median dose of 2 Gy to a total dose of 50.4 Gy. The multivariate analysis was used the Cox proportional hazard model and the Kaplan-Meier plot was used to perform local control rate (LCR), progression-free survival (PFS), and overall survival (OS) analysis. Results: The 1-year, 2-year, and 3-year LCR were 72.7%, 36.4%, and 9.1%, respectively; the 1-year, 2-year, and 3-year PFS were 69.1%, 30.9%, and 7.3%, respectively, and the median PFS time was 18 months. The 1-year, 3-year and 5-year OS were 70.9%, 28.7%, and 4.2%, respectively. Based on the multivariate analysis using the Cox proportional hazard model, the Karnofsky performance status (KPS) score and radiotherapy joint chemotherapy (RJC) method were independent prognostic-related indicators (P < 0.0001). Conclusion: BIMRT may be a safe and effective treatment for patients with peritoneal metastases, especially for patients who cannot undergo surgery. In addition, the results indicated that the patient’s KPS score and RJC method were independent prognostic-related indicators for patients survival time.
first_indexed 2024-12-10T22:35:22Z
format Article
id doaj.art-91f3369d45c347b994f200d861f3e948
institution Directory Open Access Journal
issn 1533-0338
language English
last_indexed 2024-12-10T22:35:22Z
publishDate 2020-09-01
publisher SAGE Publishing
record_format Article
series Technology in Cancer Research & Treatment
spelling doaj.art-91f3369d45c347b994f200d861f3e9482022-12-22T01:30:56ZengSAGE PublishingTechnology in Cancer Research & Treatment1533-03382020-09-011910.1177/1533033820960723Safety and Efficacy of the Metabolic Profiling of the BIMRT Utilizing 18F FDG PET-CTYa-Zheng Dang MD0Dong-Xian Zhang MS1Guo-Dong Wang MS2Hong-Liang Zhao MS3Shi-Gao Huang PhD4Jie Li BS5 Department of Radiation Oncology, 986 Hospital of People’s Liberation Army Air Force, Xi’an, Shaanxi, Province, China Department of Radiation Oncology, 986 Hospital of People’s Liberation Army Air Force, Xi’an, Shaanxi, Province, China Department of Radiation Oncology, 986 Hospital of People’s Liberation Army Air Force, Xi’an, Shaanxi, Province, China Department of Radiation Oncology, 986 Hospital of People’s Liberation Army Air Force, Xi’an, Shaanxi, Province, China Cancer Center, Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Taipa, Macao SAR, People’s Republic of China Department of Obstetrics and Gynecology, Taizhou Hospital of Zhejiang Province, Taizhou Enze Medical Center (Group), Linhai, Zhejiang Province, ChinaAim: This study aims to evaluate the safety and efficacy of fluorodeoxyglucose positron emission tomography/computed tomography ( 18 F-FDG-PET/CT) guided intensity-modulated radiation therapy (IMRT) for patients with peritoneal metastases. Patients and Methods: A total of 55 patients with peritoneal metastases were treated with 18F-FDG-PET/CT-guided IMRT (BIMRT) from January 2012 to January 2019. They were prescribed with a fraction of the median dose of 2 Gy to a total dose of 50.4 Gy. The multivariate analysis was used the Cox proportional hazard model and the Kaplan-Meier plot was used to perform local control rate (LCR), progression-free survival (PFS), and overall survival (OS) analysis. Results: The 1-year, 2-year, and 3-year LCR were 72.7%, 36.4%, and 9.1%, respectively; the 1-year, 2-year, and 3-year PFS were 69.1%, 30.9%, and 7.3%, respectively, and the median PFS time was 18 months. The 1-year, 3-year and 5-year OS were 70.9%, 28.7%, and 4.2%, respectively. Based on the multivariate analysis using the Cox proportional hazard model, the Karnofsky performance status (KPS) score and radiotherapy joint chemotherapy (RJC) method were independent prognostic-related indicators (P < 0.0001). Conclusion: BIMRT may be a safe and effective treatment for patients with peritoneal metastases, especially for patients who cannot undergo surgery. In addition, the results indicated that the patient’s KPS score and RJC method were independent prognostic-related indicators for patients survival time.https://doi.org/10.1177/1533033820960723
spellingShingle Ya-Zheng Dang MD
Dong-Xian Zhang MS
Guo-Dong Wang MS
Hong-Liang Zhao MS
Shi-Gao Huang PhD
Jie Li BS
Safety and Efficacy of the Metabolic Profiling of the BIMRT Utilizing 18F FDG PET-CT
Technology in Cancer Research & Treatment
title Safety and Efficacy of the Metabolic Profiling of the BIMRT Utilizing 18F FDG PET-CT
title_full Safety and Efficacy of the Metabolic Profiling of the BIMRT Utilizing 18F FDG PET-CT
title_fullStr Safety and Efficacy of the Metabolic Profiling of the BIMRT Utilizing 18F FDG PET-CT
title_full_unstemmed Safety and Efficacy of the Metabolic Profiling of the BIMRT Utilizing 18F FDG PET-CT
title_short Safety and Efficacy of the Metabolic Profiling of the BIMRT Utilizing 18F FDG PET-CT
title_sort safety and efficacy of the metabolic profiling of the bimrt utilizing 18f fdg pet ct
url https://doi.org/10.1177/1533033820960723
work_keys_str_mv AT yazhengdangmd safetyandefficacyofthemetabolicprofilingofthebimrtutilizing18ffdgpetct
AT dongxianzhangms safetyandefficacyofthemetabolicprofilingofthebimrtutilizing18ffdgpetct
AT guodongwangms safetyandefficacyofthemetabolicprofilingofthebimrtutilizing18ffdgpetct
AT hongliangzhaoms safetyandefficacyofthemetabolicprofilingofthebimrtutilizing18ffdgpetct
AT shigaohuangphd safetyandefficacyofthemetabolicprofilingofthebimrtutilizing18ffdgpetct
AT jielibs safetyandefficacyofthemetabolicprofilingofthebimrtutilizing18ffdgpetct